Avenue Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ATXI and buy or sell other stocks, ETFs, and their options commission-free!

About ATXI

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. 

CEO
Alexandra MacLean
CEOAlexandra MacLean
Employees
4
Employees4
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2015
Founded2015
Employees
4
Employees4

ATXI Key Statistics

Market cap
61.49M
Market cap61.49M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
12.36M
Average volume12.36M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.85
52 Week high$1.85
52 Week low
$0.20
52 Week low$0.20
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.